181 related articles for article (PubMed ID: 27385092)
1. Disruption of the EZH2/miRNA/β-catenin signaling suppresses aerobic glycolysis in glioma.
Wang Y; Wang M; Wei W; Han D; Chen X; Hu Q; Yu T; Liu N; You Y; Zhang J
Oncotarget; 2016 Aug; 7(31):49450-49458. PubMed ID: 27385092
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2.
Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Hong J; Yu H; Qi L
Stem Cell Res Ther; 2019 Dec; 10(1):381. PubMed ID: 31842978
[TBL] [Abstract][Full Text] [Related]
3. Silencing of microRNA-708 promotes cell growth and epithelial-to-mesenchymal transition by activating the SPHK2/AKT/β-catenin pathway in glioma.
Chen Y; Deng X; Chen W; Shi P; Lian M; Wang H; Wang K; Qian D; Xiao D; Long H
Cell Death Dis; 2019 Jun; 10(6):448. PubMed ID: 31171769
[TBL] [Abstract][Full Text] [Related]
4. Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis.
Tao T; Chen M; Jiang R; Guan H; Huang Y; Su H; Hu Q; Han X; Xiao J
Oncol Rep; 2017 Mar; 37(3):1430-1436. PubMed ID: 28184935
[TBL] [Abstract][Full Text] [Related]
5. Aberrant Activation of β-Catenin Signaling Drives Glioma Tumorigenesis via USP1-Mediated Stabilization of EZH2.
Ma L; Lin K; Chang G; Chen Y; Yue C; Guo Q; Zhang S; Jia Z; Huang TT; Zhou A; Huang S
Cancer Res; 2019 Jan; 79(1):72-85. PubMed ID: 30425057
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling.
Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H
EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059
[TBL] [Abstract][Full Text] [Related]
7. miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/β-catenin signaling pathway.
Zhang JJ; Chen JT; Hua L; Yao KH; Wang CY
Biomed Pharmacother; 2017 Jan; 85():472-478. PubMed ID: 27890434
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway.
Kwon H; Song K; Han C; Zhang J; Lu L; Chen W; Wu T
Am J Pathol; 2017 Oct; 187(10):2288-2299. PubMed ID: 28923203
[TBL] [Abstract][Full Text] [Related]
9. EZH2-mediated H3K27me3 enrichment on the lncRNA MEG3 promoter regulates the growth and metastasis of glioma cells by regulating miR-21-3p.
Qin WX; Shi Y; Zhu D; Li YP; Chen YH; Cui J; Cui GY; Pan JX; Ren ZY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3204-3214. PubMed ID: 32271438
[TBL] [Abstract][Full Text] [Related]
10. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
Chen Q; Zheng PS; Yang WT
Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
[TBL] [Abstract][Full Text] [Related]
11. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.
Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q
Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591
[TBL] [Abstract][Full Text] [Related]
12. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
[TBL] [Abstract][Full Text] [Related]
13. MiR-24 regulates the proliferation and invasion of glioma by ST7L via β-catenin/Tcf-4 signaling.
Chen L; Zhang A; Li Y; Zhang K; Han L; Du W; Yan W; Li R; Wang Y; Wang K; Pu P; Jiang T; Jiang C; Kang C
Cancer Lett; 2013 Feb; 329(2):174-80. PubMed ID: 23142218
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of miR-338 facilitates glioblastoma progression by de-repressing the pyruvate kinase M2-β-catenin axis.
Han B; Meng X; Chen H; Chen L; Liu X; Wang H; Liu D; Gao F; Lin L; Ming J; Sun B; Yin S; Wang R; Wu P; Cai J; Jiang C
Aging (Albany NY); 2017 Aug; 9(8):1885-1897. PubMed ID: 28858851
[TBL] [Abstract][Full Text] [Related]
15. EZH2 coupled with HOTAIR to silence MicroRNA-34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinoma.
Li CH; Xiao Z; Tong JH; To KF; Fang X; Cheng AS; Chen Y
Int J Cancer; 2017 Jan; 140(1):120-129. PubMed ID: 27594424
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-370-3p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting β-catenin.
Peng Z; Wu T; Li Y; Xu Z; Zhang S; Liu B; Chen Q; Tian D
Brain Res; 2016 Aug; 1644():53-61. PubMed ID: 27138069
[TBL] [Abstract][Full Text] [Related]
17. MiR-101 Targets the EZH2/Wnt/β-Catenin the Pathway to Promote the Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells.
Wang H; Meng Y; Cui Q; Qin F; Yang H; Chen Y; Cheng Y; Shi J; Guo Y
Sci Rep; 2016 Nov; 6():36988. PubMed ID: 27845386
[TBL] [Abstract][Full Text] [Related]
18. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
19. CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma.
Li CP; Cai MY; Jiang LJ; Mai SJ; Chen JW; Wang FW; Liao YJ; Chen WH; Jin XH; Pei XQ; Guan XY; Zeng MS; Xie D
Carcinogenesis; 2016 Jun; 37(6):557-566. PubMed ID: 27207647
[TBL] [Abstract][Full Text] [Related]
20. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
